Topiramate 70771-1658
Product NDC
70771-1658- Manufacturer
- Zydus Lifesciences Limited
- Dosage Form
- Capsule, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- January 17, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA208949
Need to source Topiramate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Topiramate | 100 mg/1 |
Drug Class
Cytochrome P450 2C19 Inhibitors [MoA]Cytochrome P450 3A4 Inducers [MoA]Decreased Central Nervous System Disorganized Electrical Activity [PE]
Packaging Options(2)
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1658-3)
90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1658-9)